Global Healthcare Analytical Testing Services Market By Service Type (Physical Characterization Services, Method Development And Others), By End User, By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2027

Healthcare Analytical Testing Services Market Overview

The healthcare global market for Analytical Testing Services was valued at US$ 12.524 Billion in 2021. This market is expected to grow at 9.2% CAGR during the forecast period. Global market growth is expected to be driven by the following key factors: an increase in analytical testing services outsourcing by biotech and pharmaceutical firms, an increase in the number of clinical trials, and a focus on biosimilar. Biosimilar offers a lower-cost treatment option than biologicals. Therefore, pharmaceutical companies have increased their investment in developing and approving biosimilars.

Global Healthcare Analytical Testing Services Market Analysis

Product Type Analysis

The market was led by the pharmaceutical product type, which held the largest share of revenue at 60% for 2021. According to product type, there are two main segments in the market: medical devices and pharmaceutical analytical testing services. Pharma companies outsource most of their analytical testing services because it involves skilled staff and specialized equipment. Emergent Bio Solutions entered into an agreement with AstraZeneca to develop a COVID-19 vaccine candidate. It was expected to provide AstraZeneca analytical testing services. Because of the increasing regulatory pressure for medical devices to be chemically analyzed, the segment of medical device products is expected to grow at a faster rate of 10% over the forecast period. Analytical testing labs will be able to reap the benefits of the combination of digital technology and biochemical testing.

End-User Analysis

According to the end user, the healthcare analytical testing services market can be divided into medical device companies, pharmaceutical and biopharmaceutical companies, and contract research organizations (CROs). These companies are increasingly outsourcing analytical testing services to improve profit margins and reduce capital expenditure. They also want to focus on their core competencies.

Key Market Segments

• By Product Type

• Medical Device
  •  Material Characterization

  • Extractable & Leachable

  • Sterility

  • Physical

  • Other Tests

• Pharmaceutical

• • Stability

  • Method Development & Validation

  • Bioanalytical

  • Other Services

• By End-User

• Contract Research Organizations

• Pharmaceutical & Biopharmaceutical Companies

• Medical Device Companies

Market Dynamics

Pfizer is the dominant biosimilar player in the United States, which supports market growth. Due to rising cases of chronic diseases, biosimilar demand is expected to rise. Analytical testing is used in biosimilar development to determine the physicochemical characteristics to determine the sameness of the biosimilar to its reference molecule. Healthcare analytical testing services will also be in demand over the forecast period. The complexity of medical and pharmaceutical devices has increased. The demand for analytical testing of medical devices, and combination drugs, is increasing. These products are complex and require sophisticated instrumentation. These companies outsource such services to pharmaceutical and medical device manufacturers.

Due to the availability of high-quality data and low costs, many pharmaceutical companies are turning to service providers from emerging countries like India. Veeda Medical Research is an Indian CRO that offers bioanalytical services to international pharma firms. In February 2021, the company entered into a partnership agreement with Somru BioScience Inc. which opened a bioanalytical lab in Ahmedabad.

In addition, there has been a rapid increase in international pharma companies developing therapeutic drugs & vaccines to treat COVID-19. These companies are increasingly outsourcing their analytical testing. SGS and AstraZeneca signed an analytical testing service agreement. This was to support AZD1222, a COVID-19-based vaccine candidate. SGS will carry out analytical testing for vaccine production in its Belgium-based lab under the terms of this agreement.

Regional Analysis

North America had a 40% revenue share in 2021. This is due to the U.S. being the home of the world’s largest market for clinical trial products. ClinicalTrials.gov data shows that more than 28% of all registry studies are in the U.S. Due to the high number of registered clinical trials, the demand for analytical testing is expected to rise. Major pharmaceutical companies are located in the country, and they do extensive R&D with a focus on biosimilar. Pfizer Inc. occupies a top position at the global level as a biosimilar firm. The company actively participates in the development and approval of biosimilars. These require analytic testing.

The Asia Pacific is expected to experience the fastest growth rate between 2023 and 2032, due to the rapid expansion of the Indian biosimilar market. Over 95 biosimilars have been approved in this country. There is also a strong biosimilar pipeline, with 40 biosimilars still in clinical development. Indian officials are expected to increase market growth by offering subsidies to biosimilar manufacturers.

Key Regions and Countries covered in thе rероrt:

• North America

  • US

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Russia

  • Spain

  • Rest of Europe

• APAC

  • China

  • Japan

  • South Korea

  • India

  • Rest of Asia-Pacific

• South America

  • Brazil

  • Argentina

  • Rest of South America

• MEA

  • GCC

  • South Africa

  • Israel

  • Rest of MEA

Market Share & Key Players Analysis:

The major market players have a number of strategic priorities. These include collaborations, expansions to their service portfolio, and mergers & Acquisitions. In order to improve their market position, many companies provide various services such as laboratory validations and other solutions. LabCorp’s drug-development business, Covance, launched preclinical to clinical and post-approval gene and cell therapy development solutions.

Pfizer Inc. and PPD Inc. entered into a three-year agreement to provide services to advance Pfizer’s drug portfolio. Pfizer expects PPD to support its drug development efforts in multiple therapeutic areas by providing clinical development and laboratory support.

Маrkеt Кеу Рlауеrѕ:

• Intertek Group

• PPD Inc.

• LabCorp

• ICON plc

• SGS SA

• Syneos Health

• Toxikon Inc.

• Eurofins Scientific

• Other Key Players

For the Healthcare Analytical Testing Services Market research study, the following years have been considered to estimate the market size: